1. Zhang, Tingting, Zhu, Mengmeng, Ma, Jialing, Xu, Suowen, Chen, Yuanli. 2024. Moscatilin inhibits vascular calcification by activating IL13RA2-dependent inhibition of STAT3 and attenuating the WNT3/β-catenin signalling pathway. In Journal of advanced research, 68, 445-457. doi:10.1016/j.jare.2024.02.020. https://pubmed.ncbi.nlm.nih.gov/38432393/
2. Chong, Siao Ting, Tan, Khee Ming, Kok, Catherine Y L, Lam, Paula Y P, Ngeow, Joanne. . IL13RA2 Is Differentially Regulated in Papillary Thyroid Carcinoma vs Follicular Thyroid Carcinoma. In The Journal of clinical endocrinology and metabolism, 104, 5573-5584. doi:10.1210/jc.2019-00040. https://pubmed.ncbi.nlm.nih.gov/31290966/
3. Liu, Ziyong, Ma, Tao, Li, Jinfang, Ren, Wei, Zhang, Zhixin. 2024. IL13RA2 promotes progression of infantile haemangioma by activating glycolysis and the Wnt/β-catenin signaling pathway. In Oncology research, 32, 1453-1465. doi:10.32604/or.2024.048315. https://pubmed.ncbi.nlm.nih.gov/39220137/
4. Verstockt, Bram, Verstockt, Sare, Creyns, Brecht, Ferrante, Marc, Breynaert, Christine. 2019. Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease. In Alimentary pharmacology & therapeutics, 49, 572-581. doi:10.1111/apt.15126. https://pubmed.ncbi.nlm.nih.gov/30663072/
5. Zeng, Jing, Zhang, Ji, Yang, Yuan-Zhong, Sai, Ke, Hu, Wan-Ming. 2020. IL13RA2 is overexpressed in malignant gliomas and related to clinical outcome of patients. In American journal of translational research, 12, 4702-4714. doi:. https://pubmed.ncbi.nlm.nih.gov/32913543/
6. Sattiraju, Anirudh, Solingapuram Sai, Kiran Kumar, Xuan, Ang, Debinski, Waldemar, Mintz, Akiva. . IL13RA2 targeted alpha particle therapy against glioblastomas. In Oncotarget, 8, 42997-43007. doi:10.18632/oncotarget.17792. https://pubmed.ncbi.nlm.nih.gov/28562337/
智鼠故事 
